Kulkarni Samarth sold CRSP
September 17, 2025 · Form 4 insider transaction
Kulkarni Samarth sold 6,000 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,000
Price
$0.00
Total value
N/A
InsiderKulkarni Samarth
RoleOfficer, Director
SecurityCommon Shares
Transaction codeG: Gift
Transaction dateSeptember 17, 2025
Filing dateSeptember 19, 2025
Shares owned after201,004
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person made a charitable contribution of common shares to a donor advised fund.